STOCK TITAN

ACURA PHARMS INC (ACUR) EPS by Year

ACUR

ACURA PHARMS INC lost $0.02 per diluted share in fiscal year 2021. The table below carries 13 fiscal years, from 2009 to 2021, and the quarters ACURA PHARMS INC has filed alongside them.

FY2021 annual
EPS (Diluted) -$0.02
Source SEC Filings (10-K/10-Q) Latest period FY2021, ended Dec 31, 2021 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ACUR EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-KFY0910-K
EPS (Diluted)-$0.02-$0.04n/m-$0.14n/m-$0.18n/m-$0.36-$0.62n/m-$0.46n/m-$1.35-$0.29n/m-$0.20-190.9%$0.22n/m-$0.27n/m-$0.35

ACUR EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2110-KQ3'2110-QQ2'2110-QQ1'2110-QQ4'2010-KQ3'2010-QQ2'2010-QQ1'2010-QQ4'1910-KQ3'1910-QQ2'1910-QQ1'1910-Q
EPS (Diluted)N/A$0.00-$0.01-$0.01n/m-$0.01-$0.02n/m$0.01n/m-$0.02$0.02n/m$0.00n/m-$0.15n/m-$0.04n/m

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More ACURA PHARMS INC financials

Frequently Asked Questions

What was ACURA PHARMS INC's diluted earnings per share in fiscal year 2021?

ACURA PHARMS INC lost $0.02 per diluted share in fiscal year 2021.

How has ACURA PHARMS INC's diluted earnings per share changed over the years?

Across the 13 fiscal years this page covers, ACURA PHARMS INC (ACUR) diluted earnings per share went from -$0.35 in fiscal year 2009 to -$0.02 in fiscal year 2021.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what ACURA PHARMS INC (ACUR) reported on that line in every period on record.